Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03917082
Title Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer (LALEAST)
Acronym LALEAST
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
BC Cancer Vancouver British Columbia V5Z4E6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field